Cancer of the ovary, fallopian tube, and peritoneum - FIGO Cancer Report 2015

open access
 

In 2014, the Gynecologic Oncology Committee of FIGO revised the staging to incorporate ovarian, fallopian tube, and peritoneal cancer in the same system. Changing the staging system required extensive international consultation. The primary site (i.e. ovary, fallopian tube, or peritoneum) is designated, where possible. When it is not possible to clearly delineate the primary site, these should be listed as “undesignated” [1] and [2].

It has been presumed that fallopian tube malignancies were rare [2].....
 Article outline

• 1. Introduction
• 2. Epidemiology
• 3. Screening
• 4. Diagnosis
• 5. Primary surgery
• 6. Chemotherapy
• 7. Secondary surgery
• 8. Follow-up for malignant epithelial tumors
• 9. Chemotherapy for recurrent epithelial malignancies
• 10. Management of epithelial tumors of low malignant potential (borderline tumors)
• 11. Management of granulosa cell tumors
• 12. Management of germ cell malignancies
• 13. Sarcoma of the ovary
• Conflict of interest
• References

---